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Health Sciences, Universiti Malaysia, Sarawak, MalaysiaA B S T R A C TObjectives: This study’s objectives were to estimate the quality of life
(QOL) of Malaysian patients with acute coronary syndrome (ACS)
during admission and at 12 months, to explore the factors associated
with the QOL, and to compare utility scores derived from tariffs from
local and foreign populations. Methods: Data collected from patients
with ACS between 2008 and 2009 for a study on cardiac rehabilitation
at the Sarawak General Hospital were used for this study. QOL data
were obtained using a validated version of the EuroQol five-
dimensional questionnaire at baseline and at 12 months. Health
utility scores were calculated using visual analogue scale scores and
utility tariffs from Malaysia and the United Kingdom. Results: Data
from 104 subjects from the earlier study was used. The mean age was
56.1 years, with 88.5% being men. The mean hospitalization duration
was 6.3 days. The mean utility score was 0.75 at baseline and 0.82 at
12 months. There was a statistically significant improvement in utilityee front matter Copyright & 2015, International S
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Selangor, Malaysia.from baseline to 12 months based on the Malaysian tariff (P ¼ 0.014)
but not with the UK tariff (P ¼ 0.086). The QOL of patients was
associated with sex and diagnosis of ST-segment elevation myocar-
dial infarction. Conclusions: Our results showed that there was a
significant improvement in the QOL from baseline to 12 months. Only
sex and diagnosis affected the QOL score at baseline because of
limited variables available for testing. It also reconfirms the impor-
tance of applying the appropriate, country-specific utility tariffs in
QOL studies. Despite limitations, the study is useful toward describing
QOL among a group of Malaysian patients with ACS.
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Acute coronary syndrome (ACS) is one of the leading causes of
morbidity and mortality globally, as well as in Malaysia [1–4]. In
2012, it accounted for 24.7% of all recorded deaths in the country
[3]. Diseases of the circulatory system also represent a significant
burden to the nation’s health system, with 7.4% of hospital-
izations [3]. These rates are poised to rise as disease patterns in
this middle-income developing country become more similar to
those of developed countries [5].
Commonly known as a “heart attack,” ACS occurs when there
is obstruction of the coronary arteries resulting in restricted blood
flow to the heart [6]. It can be classified into three intensity
categories: unstable angina (UA); non–ST-segment elevation
myocardial infarction (NSTEMI), in which coronary arteries are
partially or intermittently occluded; and ST-segment elevation
myocardial infarction (STEMI), in which there is full arterial
occlusion [6–9].As can be expected, patients with or recovering from ACS
have poorer quality of life (QOL) [10,11]. Management strategies
that help patients gain clinical and QOL improvements are
preferable over others; therefore, understanding the factors that
affect the QOL is helpful [12]. QOL outcomes may also be
prognostic in predicting subsequent morbidity and mortality in
patients with coronary disease [13]. Studies that have reported
QOL among patients with ACS are mostly from developed
countries. Among the demographic and clinical factors that have
been identified to have an impact were age [14,15], sex [14–18], a
previous cardiovascular (CV) event [16,19], angina severity [16],
type of ACS [18,20], depression [16,17,21], and physical function-
ing [15,18,19]. From Malaysia, a study by Chin et al. [4] reported
that patients’ age, percutaneous coronary intervention (PCI), and
fibrinolytic therapy were factors associated with patient mortality
but did not report QOL-related factors.
The EuroQol five-dimensional questionnaire is a five-question
descriptive system QOL instrument that also allows calculation ofociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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